Lung Cancer News

Sublobar resection conferred similar survival outcomes as lobectomy among certain patients with non-small cell lung cancer, according to phase 3 study results.

Most women with lung cancer reported some degree of sexual dysfunction following diagnosis, according to study results presented during International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Researchers at New York University, Weill Cornell Medicine and New York Genome Center have developed and tested a two-step approach that uses whole-exome sequencing to find genes and pathways that predict response to immunotherapy.

A randomized phase 3 trial designed to evaluate canakinumab as adjuvant treatment for completely resected non-small cell lung cancer failed to meet its primary endpoint, according to the agent’s manufacturer.

The Parker Institute for Cancer Immunotherapy presented $4.5 million in fellowship and scholarship awards to nine graduate and postdoctoral researchers.

The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for treatment of adults with HER2-mutated unresectable or metastatic non-small cell lung cancer.

The FDA approved capmatinib for treatment of certain adults with metastatic non-small cell lung cancer.

In this edition, lung cancer risk is high among smokers for whom screening is not recommended; the role of circulating tumor DNA in lung cancer detection and treatment is 'exciting' for field; a subset of patients with lung cancer have poor response to COVID-19 vaccines, and more.

Use of electronic medical record data alone led to overestimates of OS compared with survival curves generated using combined EMR and cancer registry data, according to study results published in JCO Clinical Cancer Informatics.

Cigarette smoking-attributable cancer deaths appeared associated with nearly 2.2 million person-years of life lost and $20.9 billion in lost earnings across the United States in 2019, according to study results.